| Mrs Jodi Bangasser, ARNP | |
|
312 9th St Sw, Waverly, IA 50677-2929 | |
| (319) 483-1365 | |
| (319) 352-3992 |
| Full Name | Mrs Jodi Bangasser |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 8 Years |
| Location | 312 9th St Sw, Waverly, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023465267 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP2300X | Nurse Practitioner - Primary Care | H095679 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cedar Valley Hospice | Waterloo, IA | Hospice |
| Care Initiatives Hospice - Cedar Falls | Cedar falls, IA | Hospice |
| St Croix Hospice | New hampton, IA | Hospice |
| Waverly Health Center | Waverly, IA | Hospital |
| Allen Hospital | Waterloo, IA | Hospital |
| Woodland Terrace | Waverly, IA | Nursing home |
| Rehabilitation Center Of Allison | Allison, IA | Nursing home |
| Clarksville Skilled Nursing & Rehab Center | Clarksville, IA | Nursing home |
| Shell Rock Senior Living | Shell rock, IA | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Waverly Health Center | 8820996762 | 36 |
News Archive
Accelerated whole breast irradiation after lumpectomy is an effective treatment for ductal carcinoma in situ (DCIS), a very common early stage and noninvasive form of breast cancer, meaning many more breast cancer patients could see their treatment times reduced by half, according to a study in the June issue of the International Journal of Radiation Oncology-Biology-Physics, the official scientific journal of the American Society for Radiation Oncology (ASTRO).
Excessive calcium contributes to harmful inflammation in ischemic stroke, and targeting it may provide doctors with a new way to improve patient outcomes, new research from the University of Virginia School of Medicine suggests.
Patients with inflammatory bowel disease (IBD) are at higher risk of melanoma, a form of skin cancer, report researchers at Mayo Clinic. Researchers found that IBD is associated with a 37 percent greater risk for the disease. The findings were presented at the Digestive Disease Week 2013 conference in Orlando, Fla.
A phase III clinical trial of 4,805 women with HER2-positive breast cancer suggests adding a second HER2 targeted medicine, pertuzumab (Perjeta), to standard of care trastuzumab (Herceptin) after surgery may help, although the benefit is modest.
Human Genome Sciences, Inc. has announced the presentation of Phase 2 clinical results demonstrating that LymphoStat-B (belimumab) achieved a sustained improvement in disease activity across multiple clinical measures, decreased the frequency of disease flares over time, and was well tolerated through 2.5 years on treatment in combination with standard of care in patients with active systemic lupus erythematosus (SLE).
› Verified 4 days ago
| Entity Name | Waverly Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598959371 PECOS PAC ID: 8820996762 Enrollment ID: O20031230000129 |
News Archive
Accelerated whole breast irradiation after lumpectomy is an effective treatment for ductal carcinoma in situ (DCIS), a very common early stage and noninvasive form of breast cancer, meaning many more breast cancer patients could see their treatment times reduced by half, according to a study in the June issue of the International Journal of Radiation Oncology-Biology-Physics, the official scientific journal of the American Society for Radiation Oncology (ASTRO).
Excessive calcium contributes to harmful inflammation in ischemic stroke, and targeting it may provide doctors with a new way to improve patient outcomes, new research from the University of Virginia School of Medicine suggests.
Patients with inflammatory bowel disease (IBD) are at higher risk of melanoma, a form of skin cancer, report researchers at Mayo Clinic. Researchers found that IBD is associated with a 37 percent greater risk for the disease. The findings were presented at the Digestive Disease Week 2013 conference in Orlando, Fla.
A phase III clinical trial of 4,805 women with HER2-positive breast cancer suggests adding a second HER2 targeted medicine, pertuzumab (Perjeta), to standard of care trastuzumab (Herceptin) after surgery may help, although the benefit is modest.
Human Genome Sciences, Inc. has announced the presentation of Phase 2 clinical results demonstrating that LymphoStat-B (belimumab) achieved a sustained improvement in disease activity across multiple clinical measures, decreased the frequency of disease flares over time, and was well tolerated through 2.5 years on treatment in combination with standard of care in patients with active systemic lupus erythematosus (SLE).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Jodi Bangasser, ARNP 338 Hickory St, Allison, IA 50602-7801 Ph: (641) 425-4346 | Mrs Jodi Bangasser, ARNP 312 9th St Sw, Waverly, IA 50677-2929 Ph: (319) 483-1365 |
News Archive
Accelerated whole breast irradiation after lumpectomy is an effective treatment for ductal carcinoma in situ (DCIS), a very common early stage and noninvasive form of breast cancer, meaning many more breast cancer patients could see their treatment times reduced by half, according to a study in the June issue of the International Journal of Radiation Oncology-Biology-Physics, the official scientific journal of the American Society for Radiation Oncology (ASTRO).
Excessive calcium contributes to harmful inflammation in ischemic stroke, and targeting it may provide doctors with a new way to improve patient outcomes, new research from the University of Virginia School of Medicine suggests.
Patients with inflammatory bowel disease (IBD) are at higher risk of melanoma, a form of skin cancer, report researchers at Mayo Clinic. Researchers found that IBD is associated with a 37 percent greater risk for the disease. The findings were presented at the Digestive Disease Week 2013 conference in Orlando, Fla.
A phase III clinical trial of 4,805 women with HER2-positive breast cancer suggests adding a second HER2 targeted medicine, pertuzumab (Perjeta), to standard of care trastuzumab (Herceptin) after surgery may help, although the benefit is modest.
Human Genome Sciences, Inc. has announced the presentation of Phase 2 clinical results demonstrating that LymphoStat-B (belimumab) achieved a sustained improvement in disease activity across multiple clinical measures, decreased the frequency of disease flares over time, and was well tolerated through 2.5 years on treatment in combination with standard of care in patients with active systemic lupus erythematosus (SLE).
› Verified 4 days ago
Teresa Anne Isaacson, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 312 9th St Sw, Waverly, IA 50677 Phone: 319-483-1390 Fax: 319-483-1399 | |
Jan Paula Davis, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 312 9th St Sw Ste 3300, Waverly, IA 50677 Phone: 319-483-1400 Fax: 319-483-1439 | |
Carissa Jo Kelm, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 312 9th St. Sw, Waverly, IA 50677 Phone: 319-352-4120 | |
Rae Gene Hovenga, NURSE PRACTITIONER Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 312 9th St Sw, Waverly, IA 50677 Phone: 319-352-4120 | |
Leeann Hoodjer, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: Waverly Health Center, 312 9th Street Sw, Waverly, IA 50677 Phone: 319-352-4120 | |
Kerri Marie Vanee, ACNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 99 E Bremer Ave Ste 100, Waverly, IA 50677 Phone: 319-239-9194 |